- Julius D, Renault F (eds). Narcotic antagonist: naltrexone progress report. NIDA Res Monogr 1976:9.
- Ling W, Wesson D. Naltrexone treatment for addicted health-care professional: a collaborative private practice experience. J Clin Psychiatry 1984;45:46-8.
- Washton A, Pottash A, Gold M. Naltrexone in addicted business executives and physicians. J Clin Psychiatry 1984;45:39-41.
- Brahen L, Henderson R, Capone T, Kordal N. Naltrexone treatment in a jail work release program. J Clin Psychiatry 1984;45:49-52.
- Cornish JW, Metzger D, Woody GE, et al. Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat 1997;14:529-34.
- Greenstein R, Arndt I, McLellan AT, O'Brien C, Evans B. Naltrexone: clinical perspectives. J Clin Psychiatry 1984;45:25-8.
- Meyer RE, Mirin SM, Altman J, McNamee HB. A behavioral paradigm for the evaluation of narcotic antagonists. Arch Gen Psychiatry 1976;33:371.
- Tennant FS, Rawson RA, Cohen AM, Mann AJ. Clinical experience with naltrexone in 160 suburban opioid addicts. J Clin Psychiatry 1984;45:42-5.
- Callahan EJ, Rawson RA, Glazer M, McLeave B, Arias R, Liberman RB. Comparison of two naltrexone treatment programs: naltrexone alone versus naltrexone plus behavior therapy. NIDA Res Monogr 1976;9:134-40.
- Rawson RA, Glazer M, Liberman RB. Behavior therapy and naltrexone for narcotic addiction. In: Krasnegor, N, ed. Behavioral approaches to analysis and treatment of substance abuse. NIDA Res Monogr. 1979;15:76-83.
- Resnick RB, Rawson RA, Washton AM, Stone-Washton N. Psychotherapy and naltrexone in opioid dependence. Presentation to the American Psychiatric Association Meeting, August, 1985: Washington, DC.
- Anton RF, Hogan I, Jalai B, Riordan CE, Kleber HD. Multiple family therapy and naltrexone in the treatment of opioid dependence. Drug Alcohol Depend 1981;8:157-68.
- Grabowski J. Effects of contingent payment on compliance with a naltrexone regime. Am J Drug Alcohol Abuse 1979;6:355-65.
- McCann MJ, Miotto K, Rawson RA, Huber A, Shoptaw S, Ling W. Outpatient non-opioid detoxification for opioid withdrawal: who is likely to benefit? Am J Addict 1997;6:1-6.
- Miotto K, McCann MJ, Rawson RA, Frosch D, Ling W. Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Drug Alcohol Depend 1997;45:131-4.
- McLellan AT, Luborsky L, Woody GE, O'Brien CP. Guide to the Addiction Severity Index. Washington, DC: US Government Printing Office, 1985.
- Derogatis LR, Lazarus L. SCL-90, Brief inventory and matching rating scales. In: Maruish ME, ed. The use of psychological testing for treatment planning and outcome assessment. Hillsdale, NJ: Lawrence Erlbaum Associates Inc., 1994:217-48.
- McNair DM, Loor M, Droppleman LE Profile of mood states. San Diego: Educational and Industrial Testing Services, 1972.
- Hulse GK, Basso, MR. The association between naltrexone compliance and daily supervision. Drug Alcohol Rev 2000;19:41-8.
- Azrin NH, Sisson RW, Meyers R, Godley M. Alcoholism treatment by disulfiram and community reinforcement therapy. J Behav Ther Exp Psychiatr 1982;13:105-12.
- Rawson RA, Obert JL, McCann MJ, Ling W. The Matrix model for the treatment of opioid addiction with naltrexone. Beverly Hills, CA: Matrix, 1992.
- Ling W, Shoptaw S, Wesson D, Rawson RA, Compton M, Klett CJ. Treatment effectiveness score as an outcome measure in clinical trials. NIDA Res Monogr 1998;175:208-20.
- Miotto K, McCann MJ, Basch J, Rawson, R, Ling, W. Naltrexone and dysphoria: fact or fiction. Am J Addict, in press.
- Lerner AG, Sigal M, Gelkopf M. Naltrexone abuse and risk of suicide. J Nerv Ment Dis 1993;181:706-7.
- Office of National Drug Control Policy Pulse check: national trends in drug abuse. Washington, DC: Office of National Drug Control Policy, 1997.
- Seoane A, Carrasco G, Cabre L, et al. Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. Br J Psychiatry 1997;17:340-5.
- Greenstein RA, O'Brien CP. Alternative pharmacotherapies for opioid addiction. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG eds. Substance abuse: a comprehenive textbook. Baltimore: Williams and Wilkins, 1995:562-573.
- Farren CK, O'Malley S, Rounsaville B. Naltrexone and opioid abuse. In: Stine S, Kosten TR, eds. New treatments for opioid dependence. New York: Guilford, 1997:104-23.
Naltrexone for opioid dependence: evaluation of a manualized psychosocial protocol to enhance treatment response
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.